Kathy Hopinkah Hannan is Director of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 167,249 shares of DNA, which is worth approximately $1.45 Million. The most recent transaction as insider was on Jun 12, 2024, when has been sold 105,263 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 167K
0% 3M change
169.82% 12M change
Total Value Held $1.45 Million

Kathy Hopinkah Hannan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Exercise of conversion of derivative security
-
105,263 Added 38.63%
167,249 Class A Common Stock
Aug 02 2022
BUY
Grant, award, or other acquisition
-
56,986 Added 47.9%
61,986 Class A Common Stock

Also insider at

OTIS
Otis Worldwide Corp Industrials
NLY
ANNALY CAPITAL MANAGEMENT INC Real Estate
CRS
CARPENTER TECHNOLOGY CORP Industrials
KHH

Kathy Hopinkah Hannan

Director
Boston, MA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if
Any

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA